Quick Hits: FDA Approves Artificial Pancreas

The Control-IQ artificial pancreas device for people living with Type 1 diabetes was developed at the University of Virginia.

A recent NBC29 article noted the FDA’s approval of a new device that will likely improve the lives of those living with Type 1 Diabetes. Gone are the days of pricing one’s finger to check blood sugar levels and manually injecting insulin thanks to a new artificial pancreas. The device is called Control-IQ, and it’s based on research and technology developed at the University of Virginia. Control-IQ monitors blood glucose levels continuously, and automatically delivers insulin when levels rise.

Fresh from the show floor: pharma packaging innovations for 2026
Serialization mandates. Containment demands. Sterile barrier requirements. Our editors found the pharma packaging innovations addressing your biggest challenges at PACK EXPO Las Vegas. Get your free curated report now.
GET YOUR COPY
Fresh from the show floor: pharma packaging innovations for 2026